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Abstract
Background: MicroRNAs (miRNAs), a class of small non-coding RNA molecules, are indicated to
play essential roles in spermatogenesis. However, little is known about the expression patterns or
function of miRNAs in human testes involved in infertility.
Methods: In this study, the miRNA expression profiles of testes of patients with non-obstructive
azoospermia (NOA) and normal controls were performed by using microarray technologies.
Results: Altered microRNA expression in NOA patients was found, with 154 differentially down-
regulated and 19 up-regulated miRNAs. These findings have been confirmed by real-time reverse
transcription-polymerase chain reaction (RT-PCR) assays on select miRNAs, including miR-302a,
miR-491-3p, miR-520d-3p and miR-383. Several down-regulated miRNA clusters in patients with
NOA were identified, such as the oncogenic potential of the mir-17-92 cluster and mir-371,2,3
cluster.
Conclusion: This is the first report that the expression of miRNAs is altered in testicular tissues
of patients with NOA, suggesting a role of miRNAs in regulating spermatogenesis in human males.
Background
Infertility is a worldwide reproductive health problem
which affects 10%–15% of couples. Half of the cases are
due to male factors, and about 60–75% of male infertility
cases are idiopathic, since the molecular mechanisms
underlying the defects remain unknown [1]. A significant
proportion of idiopathic male infertility is accompanied
by severe oligozoospermia or azoospermia. Sperma-
togenic cells are characterized with stringently regulated
spatiotemporal gene expression and strongly repressed
translation in meiotic and haploid male germ cells. For
example, impaired chromosome synapsis (marked by
synaptonemal complex protein 3 (SCP3) and SCP1) and
decreased meiotic recombination (marked by human
mutL homologue 1, MLH1, an ortholog of the Escherichia
coli Mut L mismatch repair protein) [2-4], were identified
in infertile individuals with non-obstructive azoospermia
(NOA). Such meiotic errors make these cells susceptible
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to spermatogenetic arrest and the production of aneu-
ploid gametes. However, the molecular pathways of
genetic defects in spermatogenesis are not known.
Recently, the mouse maelstrom homolog (MAEL) protein
was found in unsynapsed chromosomes of the spermato-
cyte nucleus and in the chromatoid body (a site where
RNA and RNA processing enzymes accumulate) [5]. Fur-
thermore, MAEL interacts with the microRNA (miRNA)
pathway-associated proteins mouse vasa homolog (MVH,
a germ cell specific RNA helicase), piwi-like homolog 2
(MILI) and piwi-like homolog 1 (MIWI) (Argonaute fam-
ily members). These observations suggest that miRNAs
may be involved in translational repression of meiotic
synapsis during spermatogenesis; if so, aberrant miRNA
expression would be associated with male infertility.
MicroRNAs are a family of small non-coding RNAs (typi-
cally 19–23 nt), which play important roles in regulating
post-transcriptional gene silencing through base-pair
binding to their target messenger RNAs (mRNAs) [6].
Numerous miRNAs are exclusively or preferentially
expressed in the mouse testis [7], suggesting that miRNAs
may play important roles in spermatogenesis. A role for
miRNAs in translational repression during spermatogene-
sis has been proposed, which shows that components of
the miRNA biogenetic pathway are highly concentrated in
chromatoid bodies [8,9]. Transition protein 2 (Tnp2), a
post-transcriptionally regulated testis-specific gene in
postmeiotic germ cells, was found to be regulated by miR-
122a [10]. In Dicer-deleted testis, spermatogenesis was
retarded at an early stage of proliferation and/or early dif-
ferentiation [11]. Thus, it is reasonable to speculate that
miRNAs may be involved in meiotic gene silencing, and
that alteration in miRNA expression may be a factor in
male infertility. In this study, the expression profiles of
miRNAs in the testes of men with NOA and controls were
first examined by miRNA microarrays, and the differences
in expression levels were verified by quantitative RT-PCR
for some of the differentially expressed miRNAs identi-
fied. The potential mRNA targets of the miRNAs were pre-
dicted using a bioinformatics approach.
Methods
Sample collection and RNA extraction
Testicular samples were obtained from the First Affiliated
Hospital of Anhui Medical University (Hefei, China).
Three patients (ages 22–30 years) with NOA and two
patients (ages 60–63 years) undergoing orchiectomy for
prostate carcinoma (controls) were recruited for this
study. The testicular histology of the NOA patients
showed a global early maturation arrest pattern. Two
semen analyses indicated azoospermia. An ideal study
population as normal controls would consist of volun-
teers of known fertility, but difficulties in acquiring testic-
ular samples makes this impractical. Instead, samples
were analyzed from urology patients who had no history
of meiotic defects or infertility and histological examina-
tion showed normal spermatogenesis. In addition, none
of the controls were exposed to adjuvant hormonal ther-
apy prior to orchiectomy. Informed consent was obtained
from all patients, and this study received ethical approval
from the institutional review boards of the University of
Science and Technology of China and the Anhui Medical
University.
Immediately after retrieval, testicular tissues were snap-
frozen in liquid nitrogen and stored at -80°C until proc-
essed. Total RNA was isolated using Trizol reagent (Invit-
rogen, USA), following the manufacturer's protocol. The
quality of extracted RNA was measured using UV absorb-
ance and denaturing agarose gel electrophoresis.
MicroRNA microarray analysis
MicroRNA expression profiles of testicular tissues from
NOA patients and controls were generated by applying
the miRCURY Locked Nucleic Acid (LNA) microarray
platform (Exiqon, Denmark). All procedures were carried
out according to manufacturer's protocol. Briefly, 1 μg
total RNA was dual-labelled with dyes spectrally equiva-
lent to the Cy3™ and Cy5™ fluorophores, using a miR-
CURY™ Array Power Labelling kit (Exiqon, Denmark).
Labelled miRNAs were used for hybridization on a miR-
CURY™ LNA microRNA Array containing Tm-normalized
capture probes for 582 human miRNAs. Microarrays with
labelled samples were hybridized at 56°C for overnight
using a heat-shrunk hybridization bag (Phalanx Hybridi-
zation Assembly, Phalanx Biotech, Taiwan, China) and
washed using miRCURY™ Array Wash buffer kit (Exiqon,
Denmark).
Slides were scanned using a Genepix 4000B laser scanner
(Axon Instruments, USA) and microarray images were
analyzed using Genepix Pro 6.0 software (Axon Instru-
ments, USA). The patients with NOA group and the
patients undergoing orchiectomy for prostate carcinoma
group, were pooled to represent the study and the control
group. Differentially expressed miRNAs were defined as
genes whose expression in the study group is consistently
altered two-fold (either greater or less) compared to the
control group. The 2-fold cut-off is a default for many
microarray experiments because it can reflect the variabil-
ity in the population of samples. Hierarchical clustering
for differentially expressed miRNAs was generated by
using standard correlation as a measure of similarity.
Bioinformatics analysis
Genomic coordinates were determined for each miRNA,
and mapped to a specific chromosomal region in the
human genomes using miRBase: Sequence Release 10.1
[12,13] combined with the UCSC Genome Browser [14].Reproductive Biology and Endocrinology 2009, 7:13 http://www.rbej.com/content/7/1/13
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Patterns of miRNA gene clustering and chromosomal dis-
tribution of differentially expressed miRNAs in the
human genome were also determined.
To better understand the function of miRNAs, putative
mRNA targets of differentially expressed miRNAs were
predicted by four algorithms: miRBase Targets [15], Tar-
getScan [16], DIANA-microT [17] and PicTar [18]. The
intersections of the four algorithms were obtained from
miRGen [19].
Real-time quantitative PCR
Real-time quantitative PCR was performed to confirm the
array results. Reverse transcriptase reactions contained
700 ng of purified total RNA, 20 nM stem-loop RT primer
(Table 1), 1 × RT buffer (Epicentre, USA), 0.125 mM each
of dATP, dGTP, dCTP and dTTP (HyTest Ltd., Finland), 1
U/μl MultiScribe reverse transcriptase (Epicentre) and 0.6
U/μl RNase Inhibitor (Epicentre, USA). Using the Gene
Amp PCR System 9700 (Applied Biosystems, USA), 20 μl
reactions were performed with the following thermal
cycling parameters: 30 min at 16°C, 42 min at 42°C, 5
min at 85°C and then held at 4°C. All reverse tran-
scriptase reactions, including no-template controls and RT
minus controls, were run in duplicate. Reactions for qRT-
PCR were conducted in triplicate, using a Rotor-Gene
3000 Realtime PCR instrument (Corbett Research, Aus-
tralia). Each reaction mixture contained 1 × PCR buffer
(Promega, USA), 1.5 mM MgCl2 (Promega, USA), 0.25
mM each of dATP, dGTP, dCTP and dTTP (HyTest Ltd.,
Finland), 1 U DNA polymerase (Promega, USA), 0.4 μM
of each primer (Table 1), 0.25 × SYBR Green I (Invitrogen,
USA), 1 μl cDNA, and deionized water to a total volume
of 25 μl. Reactions were run with the following thermal
cycling parameters: 95°C for 5 minutes followed by 40
cycles of 95°C for 10 seconds (denaturation) and 60°C
for 60 seconds. The threshold cycle (Ct) is defined as the
fractional cycle number at which the fluorescence passes
the fixed threshold, and each sample was normalized on
the basis of its endogenous U6 RNA content. Data analysis
was performed by using Rotor-gene v6.0 software (Cor-
bett Research, Australia).
In situ hybridization
To investigate the cell-specific distribution of miRNA in
normal and NOA tissues, in situ hybridizations were per-
formed using 5'end digoxigenin (DIG)-labelled LNA
modified DNA oligonucleotides (LNAs) complementary
to the mature miRNA supplied by Exiqon A/S (Denmark).
In this study, the expression of miR-383 was examined in
testicular tissues. LNAs had the following sequences: LNA-
miR-383, 5'-agccacaatcaccttctgatct-3'. Furthermore, LNA-
scrambled, 5'-gtgtaacacgtctatacgccca-3' serves as negative
control.
In situ hybridization in human testis tissue was performed
essentially as described by Obernosterer et al.(2007) [20].
After fixation with 4% paraformaldehyde for 15 min, 10
μm testis sections were immersed and stirred gently in 0.1
M ethanolamine and 2.5% acetic anhydride for 10 min to
block endogenous alkaline phosphatase activity. The
slides were treated with 5 μg/ml proteinase K for 3 min,
followed by extensive washing with PBS. Pre-hybridiza-
tions were performed for 6 hr in hybridization oven at a
temperature of 52°C with 700 μl pre-hybridization buffer
(50% formamide, 5 × SSC, 5 × Denhardt's, 200 μg/ml
yeast RNA, 500 μg/ml salmon sperm DNA, 2% Roche
blocking reagents and DEPC-treated water). 1 pmol LNA
probe was added to 150 μl denaturizing hybridization
buffer (50% formamide, 5 × SSC, 5 × Denhardt's, 200 μg/
ml yeast RNA, 500 μg/ml salmon sperm DNA, 2% Roche
blocking reagents, 0.25% CHAPS, 0.1% tween and DEPC-
treated water). After denatured by heating up to 80°C for
5 min and then quickly placed on ice, the probe mixture
was pipetted onto the tissues. Glass coverslips were
applied, and the slides were hybridized overnight at the
pre-hybridization temperature. Sections were soaked in
pre-warmed 60°C 5 × SSC to remove the coverslips, and
incubated in 0.2 × SSC at 60°C for 1 h. Slides were then
incubated in B1 solution (0.1 M Tris pH 7.5/0.15 M NaCl)
at room temperature for 10 min. After pretreated in 20%
sheep serum (Santa Cruz, USA) diluted with B1 solution
at room temperature for 1 hr, the sections were incubated
overnight at 4°C in 10% sheep serum containing anti-
Digoxigenin-AP FAB fragments (Roche, USA; 1:250). Sec-
Table 1: Oligonucleotides used in this study.
Primer set name Reverse transcriptase reaction primer (5' to 3') Real-time quantitative PCR primer (5' to 3')
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tions were then washed three times for 5 min in B1 solu-
tion at room temperature and equilibrated for 10 min in
B3 solution (0.1 M Tris pH 9.5/0.1 M NaCl/50 mM
MgCl2). Staining with NBT/BCIP (Roche, USA) was done
overnight at room temperature. When each probe had
yielded a strong signal, or until the negative control began
to show background label, reactions were stopped by
washing the slides for 3 × 10 min in 1 × PBS. Finally, the
slides were mounted with the aqueous mounting medium
sealed with nail polish. Signals were visualized under a
standard light microscopy.
Results
Differential expression of miRNAs between normal and 
NOA testes
By employing a highly sensitive, high-throughput and
specific miRCURY™ LNA microarray platform, miRNA
expression profiles for testicular tissues were determined
from 3 patients with NOA and 2 controls. Among all
human miRNAs spotted on the chip, genes were consid-
ered to have significant differential expression if they were
up- or down-regulated at least two-fold. A total of 173
miRNAs were found to be differentially expressed in NOA
patients compared to controls, with 19 up-regulated miR-
NAs (See additional file 1: Table S1 for Differentially up-
regulated miRNAs in NOA patients.) and 154 differen-
tially down-regulated (See additional file 2: Table S2 for
Differentially down-regulated miRNAs in NOA patients.).
Based on these differentially expressed miRNAs, a tree
with clear distinction between control males and NOA
patients was generated by cluster analysis (Fig. 1). In addi-
tion, at least 7.8% (12) of the 154 differentially down-reg-
ulated miRNAs appear to be the testicular miRNAs (Table
2), contrasted with the expression profiles of the mouse
testicular miRNAs reported previously [7].
To confirm the results obtained by microarray analysis,
quantitative real-time RT-PCR analysis of normal and
NOA testicular samples was performed for miR-302a,
miR-491-3p, miR-520d-3p and miR-383. Real-time PCR
confirmed microarray analysis results: expression of miR-
302a and miR-491-3p was up-regulated (Fig. 2) and miR-
520d-3p and miR-383 was down-regulated (Fig. 2) in
patients with NOA. Furthermore, in situ hybridization
data were also verified microarray analysis results: miR-
383 expression (major in primary spermatocyte) levels
were found to be down-regulated in patients with NOA
(Fig. 3).
Genomic location of differentially expressed miRNAs
Chromosomal locations of miRNA genes have frequently
provided important insight into the roles of miRNAs in
specific diseases. By mapping differentially expressed
miRNA genes onto the chromosomes, genes encoding
down-regulated miRNAs were found on all chromosomes
Hierarchical clustering of miRNA in testicular tissue samples Figure 1
Hierarchical clustering of miRNA in testicular tissue 
samples. Testicular tissue samples were clustered according 
to the expression profile of 173 two-fold differentially 
expressed miRNAs between 3 NOA patients and 2 controls. 
All samples were properly assigned to the correct class. The 
key color bar indicates that miRNA expression levels 
increased from green to red color compared to controls 
(dark color indicates the expression level is close to that of 
controls). N: controls; A: NOA patients.Reproductive Biology and Endocrinology 2009, 7:13 http://www.rbej.com/content/7/1/13
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but the Y chromosome (Fig. 4A; also see additional file 2:
Table S2 for Differentially down-regulated miRNAs in
NOA patients.). Of all the chromosomes, chromosomes
14, 19 and X appear to contain the most down-regulated
miRNA genes (a total of 62 miRNAs; 35.6%). Chromo-
somes 10, 16 and 21 contained only one down-regulated
miRNA gene. The most up-regulated miRNA genes were
located on chromosome 17. Notably, miR-663 was
located on chromosome 20 ph (the heterochromatic
region on the p arm), in which the genes are usually tran-
scriptionally silent [21].
Clusters of miRNAs within the human genome were also
identified. Expressions of 12 of 13 members of a miRNA
cluster located at human chromosome 14q32.31 were
down-regulated in infertile men, with only miR-654-5p
Table 2: Summary of down-regulated miRNAs that appear to be the testicular miRNAs†
human miRNA Mean fold-change†† Sequence (5'-3') mouse miRNA Sequence (5'-3')
hsa-let-7f -0.33 tgaggtagtagattgtatagtt let-7f TGAGGTAGTAGATTGTATAGT
hsa-let-7f-2* -0.11 ctatacagtctactgtctttcc *let-7f-1-3p CTATACAATCTATTGCCTTCCC
hsa-let-7i* -0.13 ctgcgcaagctactgccttgct *let-7i-3p CTGCGCAAGCTACTGCCTTGCT
has-miR-181a -0.21 aacattcaacgctgtcggtgagt mir-181c AACATTCAACCTGTCGGTGAGT
hsa-miR-19a -0.36 tgtgcaaatctatgcaaaactga mir-19b TGTGCAAATCCATGCAAAACTGA
hsa-miR-20b -0.44 caaagtgctcatagtgcaggtag *mir-20b CAAAGTGCTCATAGTGCAGGTA
hsa-miR-29c -0.45 tagcaccatttgaaatcggtta mir-29a(+1) TAGCACCATCTGAAATCGGTTA
hsa-miR-30a* -0.31 ctttcagtcggatgtttgcagc mir-30a-3p CTTTCAGTCGGATGTTTGCAGC
hsa-miR-30d* -0.23 ctttcagtcagatgtttgctgc mir-30a-3p CTTTCAGTCGGATGTTTGCAGC
hsa-miR-34b* -0.31 taggcagtgtcattagctgattg mir-34b TAGGCAGTGTAATTAGCTGATTG
hsa-miR-449a -0.36 tggcagtgtattgttagctggt mir-449 TGGCAGTGTATTGTTAGCTGGTTG
hsa-miR-652 -0.35 aatggcgccactagggttgtg mir-652 AATGGCGCCACTAGGGTTGTGC
hsa-miR-92a -0.30 tattgcacttgtcccggcctgt hsa-miR-92 TATTGCACTTGTCCCGGCCTG
†Based on expression profiles of the mouse testicular miRNAs from Ro et al. (2007) [7]
††Infertile vs. control.
Confirmation of microarray data by quantitative real-time PCR Figure 2
Confirmation of microarray data by quantitative real-time PCR. Quantitative real-time PCR analysis confirmed 
microarray data: miR-302a and miR-491-3p was up-regulated and miR-520d-3p and miR-383 was downregulated in NOA 
patients. Error bars indicate the SEM.Reproductive Biology and Endocrinology 2009, 7:13 http://www.rbej.com/content/7/1/13
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up-regulated (See additional file 3: Table S3 for Several
differentially expressed miRNA clusters in NOA patients.).
Two miRNA clusters located at chromosome 19q13.42
were identified. One is the mir-371,2,3 cluster, consisting
of differentially down-regulated miR-372, miR-373 and
up-regulated miR-371-5p in patients with NOA; the other
cluster, of 13 differentially down-regulated miRNAs (See
additional file 3: Table S3 for Several differentially
expressed miRNA clusters in NOA patients.), was reported
as a new cluster of non-conserved miRNAs [22]. Of partic-
ular note is that several members of the mir-17-92 family
occur relatively infrequently in NOA patients. These miR-
NAs are encoded by three paralogous clusters located at
chromosome 13q31.3 (the mir-17  cluster, containing
miR-18a*, miR-19a, miR-19b-1* and miR-92-1), chro-
mosome Xq26.2 (the mir-106a cluster, containing miR-
18b*, miR-20b and miR-92-2) and chromosome 7q22.1
(the mir-106b cluster, containing miR-93 and miR-93*)
(Fig. 4B) [23].
Putative miRNA target gene prediction
To determine if miRNA may modulate mRNA levels in
infertile testis, four programs (see Materials and Methods)
were used to predict targets for differentially expressed
miRNAs. Only the targets that were found from at least
two of these algorithms were considered, in order to
increase the stringency of the analysis. For example, the
potential targets for several down-regulated miRNAs,
including tissue inhibitor of metalloproteinase 3
(TIMP3), SRY (sex determining region Y)-box 9 (SOX9)
and Growth arrest and DNA-damage-inducible, gamma
(GADD45G), were shown to be increased in infertile testis
(Table 3) [24].
Discussion
The meiotic and haploid phases of spermatogenesis are
characterized by high transcriptional activity but sup-
pressed translational activity. Post-transcriptional control
of gene expression in these phases can be mediated by
sequences in the 5' and 3'-untranslated regions (UTRs) of
mRNAs where they may be regulated by miRNAs, indicat-
ing that miRNAs might play important roles in sperma-
togenesis [25]. In the current study, using the microarray
assay, altered expression of miRNAs in the testes of
patients with NOA was identified for the first time, sug-
gesting that aberrant miRNA expression may contribute to
spermatogenesis arrest in human males.
Many clusters of miRNAs have been identified within the
human genome [22,26]. One of the largest miRNA clus-
In situ hybridization of miRNA in human testes Figure 3
In situ hybridization of miRNA in human testes. In situ hybridization analyses using 5' DIG-conjugated, LNA-modified 
DNA probe complementary to miR-383 was performed on 10-μm frozen sections of the testes of NOA patient and normal 
control. A, D: HE stain of normal (A) and NOA testes (E); B, E: In the testis of normal control (B), miR-383 was highly 
expressed in primary spermatocyte (PS) and lowly expressed in spermatid (Sp); whereas the expression of miR-383 in NOA 
patient (E) is decreased compared with control. C, F: The negative control of normal (C) and NOA testes (F), where the tis-
sues were treated without using DIG-labelled probe. Scale bar = 50 μm.Reproductive Biology and Endocrinology 2009, 7:13 http://www.rbej.com/content/7/1/13
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ters identified to date is hsa-miR-127, a cluster comprised
of greater than 50 members residing on an imprinted
region of human chromosome 14q32 [22]. Another clus-
ter on chromosome 19 located at positions 58861745–
58961404 (HG17), is the largest non-conserved miRNA
cluster ever reported and is comprised of 54 miRNAs [22].
Moreover, almost all the known miRNAs encoded by
genes on the X-chromosome are expressed in the testis
[7,22]. In the present study, preferential down-regulation
of miRNAs in chromosomes 14, 19 and X was found in
Genomic locations of differentially-expressed miRNAs associated with spermatogenesis arrest Figure 4
Genomic locations of differentially-expressed miRNAs associated with spermatogenesis arrest. A. Chromosomal 
distribution of differentially-expressed miRNA genes identified in patients with NOA. 19 up-regulated (hollow bar) and 154 
down-regulated miRNAs (solid bar) were located and numbered on each of the chromosomes. B. Chromosomal locations of 
human mir-17-92 family identified in patients with NOA. The mir-17-92 family consists of three paralogous clusters: the mir-17 
cluster (located at chromosome13q31.3), the mir-106a cluster (located at chromosome Xq26.2) and the mir-106b cluster 
(located at chromosome 7q22.1). Names of the miRNA precursors are written above the boxes. The position of the mature 
miRNA is indicated by a dark box. The expression levels of 8 members of this family were differentially down-regulated in tes-
ticular tissues for NOA patient (gray), while other members show no significant difference in expression levels between nor-
mal and infertile men (white).Reproductive Biology and Endocrinology 2009, 7:13 http://www.rbej.com/content/7/1/13
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NOA patient testicular tissues. These findings suggest that
expression of miRNAs in regions of 14q32.31, 19q13.42
and the X chromosome could be important in sperma-
togenesis.
Among the differentially expressed miRNAs, it is interest-
ing to note that several members of the mir-17-92 cluster
and mir-371,2,3 cluster are downregulated in NOA testic-
ular tissue. These miRNAs are potential novel oncogenes
participating in the development of human testicular
germ cell tumors [27,28]. The mir-17-92 cluster is highly
expressed in carcinoma in situ (CIS) testis and inhibits
apoptosis by translationally down-regulating E2F tran-
scription factor 1(E2F1) in CIS cells [28]. The expression
of miR-372 and miR-373 permits proliferation and tum-
origenesis of primary human cells by harboring both
oncogenic RAS and active wild-type p53 [27]. Therefore,
mir-17-92 cluster and miR-372/miR-373 may down-regu-
late apoptosis genes and potentially have a role in inhib-
iting apoptosis. In this study, low expression of these
miRNAs was found in NOA patients, which may contrib-
ute to increased apoptosis in the testes of patients with
NOA [29].
The prediction of putative mRNA targets for differentially
expressed miRNAs will help to characterize the miRNAs
involved in biological processes. For example, three possi-
ble target genes for down-regulated miRNAs, TIMP3,
SOX9  and  GADD45G, were significantly increased in
infertile testis [24]. TIMP-3, a potential target of four
down-regulated miRNAs (miR-1, miR-181a, miR-221 and
miR-9*), is thought to play an active role in testicular
development and differentiation [30]. The transcription
factor SOX9, a putative target of miR-145, is required for
Sertoli cell maturation and normal spermatogenesis [31].
As a potential target of miR-383, GADD45G can induce
apoptosis and inhibit cell growth in response to stress
shock [32]. Abnormal expressions of these proteins may
have a significant impact on male infertility.
During meiotic prophase I of spermatogenesis, synapsis
of homologous chromosomes and recombination are
essential for the formation of haploid spermatozoa
[33,34]. Impaired chromosome synapsis and decreased
meiotic recombination can lead to meiotic arrest in sper-
matogenesis [2,4,35]. In this study, the four differentially
expressed miRNAs were chosen to be confirmed in NOA
patients by quantitative RT-PCR due to their potential role
in regulating meiotic recombination- and synapsis-related
genes. For example, one of the predicted target genes of
miR-302a and miR-383 is MLH1, while miR-491-3p and
miR-520d-3p is SCP1 and SCP3, respectively. The miR-
383 was chosen for further in situ hybridization analysis
because the relative abundance of this miRNA was found
be in meiotic prophase [36]. Whether the altered patterns
of miRNA expression contribute to defects in chromo-
some synapsis and recombination in NOA patients awaits
further study.
In summary, miRNA expression in testes was profiled and
results were compared between patients with NOA and
control men. Several miRNA clusters were also examined.
However, the cellular origins of testicular miRNAs remain
unknown. Azoospermic men with testicular failure have
different problems ranging from Sertoli cell-only pattern
to maturation arrest, or hypospermatogenesis. Therefore,
analysis of the cellular origins and the target genes of these
differentially expressed miRNAs in even larger popula-
tions of infertile men is warranted in order to shed light
on their regulatory roles in spermatogenesis and male
infertility.
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